9030 Human Mena (hMena) and isoforms hMena+11a and hMenadeltaV6, estrogen receptor-beta (ER-B), epidermal growth factor receptor -1 and -2 (EGFR/HER-2) expression as prognostic factors in node-negative Non-Small-Cell Lung Cancer (NSCLC)

E.Bria; M.Mottolese; I.Sperduti; P.Visca; B.Antoniani; F.Facciolo; F. DiModugno; F.Cognetti; P.Nisticò; M.Milella

首页> 外文期刊>European Journal of Cancer Supplements >9030 Human Mena (hMena) and isoforms hMena+11a and hMenadeltaV6, estrogen receptor-beta (ER-B), epidermal growth factor receptor -1 and -2 (EGFR/HER-2) expression as prognostic factors in node-negative Non-Small-Cell Lung Cancer (NSCLC)

【24h】

9030 Human Mena (hMena) and isoforms hMena+11a and hMenadeltaV6, estrogen receptor-beta (ER-B), epidermal growth factor receptor -1 and -2 (EGFR/HER-2) expression as prognostic factors in node-negative Non-Small-Cell Lung Cancer (NSCLC)

机译：9030人Mena（hMena）及其同工型hMena + 11a和hMenadeltaV6，雌激素受体-β（ER-B），表皮生长因子受体-1和-2（EGFR / HER-2）表达是淋巴结阴性非-小细胞肺癌（NSCLC）

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2009年第2期|共1页
作者
E.Bria; M.Mottolese; I.Sperduti; P.Visca; B.Antoniani; F.Facciolo; F. DiModugno; F.Cognetti; P.Nisticò; M.Milella;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
专利

1. A phase I study of the humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody EMD 72000 (matuzumab) in combination with paclitaxel in patients with EGFR-positive advanced non-small-cell lung cancer (NSCLC). [J] . Kollmannsberger C, Schittenhelm M, Honecker F, Annals of oncology: official journal of the European Society for Medical Oncology . 2006,第6期

机译：人源化单克隆抗表皮生长因子受体（EGFR）抗体EMD 72000（matuzumab）与紫杉醇联合用于EGFR阳性晚期非小细胞肺癌（NSCLC）患者的I期研究。
2. A phase I study of the humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody EMD 72000 (matuzumab) in combination with paclitaxel in patients with EGFR-positive advanced non-small-cell lung cancer (NSCLC) [J] . C. Kollmannsberger, M. Schittenhelm, F. Honecker, Annals of Oncology . 2006,第6期

机译：人源化单克隆抗表皮生长因子受体（EGFR）抗体EMD 72000（matuzumab）与紫杉醇联合用于EGFR阳性晚期非小细胞肺癌（NSCLC）患者的I期研究
3. Expression of epidermal growth factor receptor (EGFR) and downstream-activated peptides in surgically excised non-small-cell lung cancer (NSCLC). [J] . Mukohara T, Kudoh S, Yamauchi S, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2003,第2期

机译：表皮生长因子受体（EGFR）和下游激活肽在手术切除的非小细胞肺癌（NSCLC）中的表达。
4. Effect of preoperative cancer treatment on epidermal growth factor receptor (EGFR) receptor expression level in ABY-029 guided sarcoma surgery [C] . Xiaochun Xu, Kimberley S Samkoe, Eric R. Henderson Society of Photo-Optical Instrumentation Engineers;Conference on Molecular-Guided Surgery: Molecules, Devices, and Applications . 2020

机译：术前癌症治疗对ABY-029导向肉瘤手术中表皮生长因子受体（EGFR）受体表达水平的影响
5. Effects of the non-steriodal anti-inflammatory drug (NSAID) sulindac on epidermal growth factor receptor (EGFR) expression and signaling in colorectal cancer [D] . Pangburn, Heather Ann 2007

机译：非甾体类抗炎药（NSAID）舒林酸对大肠癌表皮生长因子受体（EGFR）表达和信号传导的影响
6. Molecular Cloning of hMena (ENAH) and Its Splice Variant hMena+11a: Epidermal Growth Factor Increases Their Expression and Stimulates hMena+11a Phosphorylation in Breast Cancer Cell Lines [O] . Francesca Di Modugno, Lucia DeMonte, Michele Balsamo, -1

机译：hMena（ENAH）及其剪接变体hMena + 11a的分子克隆：表皮生长因子增加其表达并刺激乳腺癌细胞系中的hMena + 11a磷酸化。
7. Molecular cloning of hMena (ENAH) and its splice variant hMena+11a: epidermal growth factor increases their expression and stimulates hMena+11a phosphorylation in breast cancer cell lines. [O] . DI MODUGNO F, DE MONTE L, BALSAMO M, 2007

机译：hMena（ENAH）及其剪接变体hMena + 11a的分子克隆：表皮生长因子增加其表达并刺激乳腺癌细胞系中的hMena + 11a磷酸化。
8. Regulation of Epidermal Growth Factor Receptor (EGFR) Expression by PML in HumanBreast Cancer [R] . Chin, K. V. 1995

机译：pmL对人乳腺癌中表皮生长因子受体（EGFR）表达的调节作用

9030 Human Mena (hMena) and isoforms hMena+11a and hMenadeltaV6, estrogen receptor-beta (ER-B), epidermal growth factor receptor -1 and -2 (EGFR/HER-2) expression as prognostic factors in node-negative Non-Small-Cell Lung Cancer (NSCLC)

著录项

相似文献

相关主题

期刊订阅